Correlation Between Teva Pharmaceutical and El Al

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Teva Pharmaceutical and El Al at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Teva Pharmaceutical and El Al into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Teva Pharmaceutical Industries and El Al Israel, you can compare the effects of market volatilities on Teva Pharmaceutical and El Al and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Teva Pharmaceutical with a short position of El Al. Check out your portfolio center. Please also check ongoing floating volatility patterns of Teva Pharmaceutical and El Al.

Diversification Opportunities for Teva Pharmaceutical and El Al

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Teva and ELAL is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Teva Pharmaceutical Industries and El Al Israel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on El Al Israel and Teva Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Teva Pharmaceutical Industries are associated (or correlated) with El Al. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of El Al Israel has no effect on the direction of Teva Pharmaceutical i.e., Teva Pharmaceutical and El Al go up and down completely randomly.

Pair Corralation between Teva Pharmaceutical and El Al

Assuming the 90 days trading horizon Teva Pharmaceutical Industries is expected to generate 0.62 times more return on investment than El Al. However, Teva Pharmaceutical Industries is 1.61 times less risky than El Al. It trades about 0.13 of its potential returns per unit of risk. El Al Israel is currently generating about 0.07 per unit of risk. If you would invest  280,300  in Teva Pharmaceutical Industries on August 28, 2024 and sell it today you would earn a total of  333,200  from holding Teva Pharmaceutical Industries or generate 118.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Teva Pharmaceutical Industries  vs.  El Al Israel

 Performance 
       Timeline  
Teva Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Teva Pharmaceutical Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
El Al Israel 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in El Al Israel are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, El Al sustained solid returns over the last few months and may actually be approaching a breakup point.

Teva Pharmaceutical and El Al Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Teva Pharmaceutical and El Al

The main advantage of trading using opposite Teva Pharmaceutical and El Al positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Teva Pharmaceutical position performs unexpectedly, El Al can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in El Al will offset losses from the drop in El Al's long position.
The idea behind Teva Pharmaceutical Industries and El Al Israel pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges